Source:http://linkedlifedata.com/resource/pubmed/id/17551669
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2007-10-2
|
pubmed:abstractText |
COX-2-derived PGE2 has been implicated in the development of various types of cancers. However, the exact mechanism of PGE2-induced cancer cell proliferation and survival is still unclear. In the current study, the mechanism underlying PGE2-enhanced Erk phosphorylation in human cholangiocarcinoma cells was determined. The intracellular concentration of calcium in three cholangiocarcinoma cell lines was measured using a laser confocal scanning microscope and the expression levels of Erk and EGFR phosphorylation were determined by Western blot analyses. The activation of EP1 receptors involved in PGE2-stimulated Erk activation and increasing the intracellular concentration of calcium was elucidated using selective EP1 receptor subtype antagonists and agonist. The intracellular calcium chelator, BAPTA-AM, was shown to block PGE2-induced Erk and EGFR phosphorylation. PGE2-induced Erk phosphorylation was abrogated by pretreatment with the EGF receptor kinase inhibitor, AG1478. Our findings suggest that in human cholangiocarcinoma cells, PGE2-enhanced phosphorylation of Erk is, at least in part, mediated through EP1 receptors and EGFR phosphorylation induced by increases in the intracellular concentration of calcium.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Dinoprostone,
http://linkedlifedata.com/resource/pubmed/chemical/Extracellular Signal-Regulated MAP...,
http://linkedlifedata.com/resource/pubmed/chemical/PTGER1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Prostaglandin E,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Prostaglandin E, EP1...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0300-8177
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
305
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
19-26
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17551669-Bile Duct Neoplasms,
pubmed-meshheading:17551669-Bile Ducts, Intrahepatic,
pubmed-meshheading:17551669-Calcium,
pubmed-meshheading:17551669-Cell Line, Tumor,
pubmed-meshheading:17551669-Cholangiocarcinoma,
pubmed-meshheading:17551669-Dinoprostone,
pubmed-meshheading:17551669-Extracellular Signal-Regulated MAP Kinases,
pubmed-meshheading:17551669-Humans,
pubmed-meshheading:17551669-MAP Kinase Signaling System,
pubmed-meshheading:17551669-Phosphorylation,
pubmed-meshheading:17551669-Receptor, Epidermal Growth Factor,
pubmed-meshheading:17551669-Receptors, Prostaglandin E,
pubmed-meshheading:17551669-Receptors, Prostaglandin E, EP1 Subtype
|
pubmed:year |
2007
|
pubmed:articleTitle |
Prostaglandin E2 enhances mitogen-activated protein kinase/Erk pathway in human cholangiocarcinoma cells: involvement of EP1 receptor, calcium and EGF receptors signaling.
|
pubmed:affiliation |
Laboratory of Reproductive Medicine, Department of Pathology, Nanjing Medical University, 140 Hanzhong Road, Nanjing, Jiangsu, 210029, P.R. China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|